BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1100342)

  • 1. [Side-effects of L-dopa therapy].
    Girke W; Xenakis Ch
    Dtsch Med Wochenschr; 1975 Oct; 100(42):2165-9. PubMed ID: 1100342
    [No Abstract]   [Full Text] [Related]  

  • 2. [Review of problems in the treatment of the parkinsonian syndrome with L-dopa].
    Piccirilli M; Quartesan R
    Clin Ter; 1976 Mar; 76(5):467-77. PubMed ID: 991553
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapy of Parkinsonian syndrome using L-dopa. Current state and problems].
    Fischer PA
    Nervenarzt; 1974 Dec; 45(12):617-27. PubMed ID: 4614096
    [No Abstract]   [Full Text] [Related]  

  • 4. [The problem of side effects after a treatment with L-dopa in the Parkinson's syndrome: clinical and animal studies (author's transl)].
    Sommer H; Fischer GJ; Quandt J
    Folia Clin Int (Barc); 1974 Oct; 24(10):681-95. PubMed ID: 4279185
    [No Abstract]   [Full Text] [Related]  

  • 5. The effects of combining carbidopa with levodopa for Parkinson's disease.
    Martin WE; Tolosa ES; Loewenson RB; Lee MC; Resch JA; Baker AB
    Geriatrics; 1975 Dec; 30(12):39-44. PubMed ID: 1104406
    [No Abstract]   [Full Text] [Related]  

  • 6. [L-dopa-decarboxylase inhibitor combination preparation (Sinemet) in parkinsonism and syndromes imitating parkinsonism. 1 year's experience with 34 patients].
    Holmsen R
    Tidsskr Nor Laegeforen; 1976 Feb; 96(4):225, 234-6. PubMed ID: 1251394
    [No Abstract]   [Full Text] [Related]  

  • 7. [Collateral effects of therapy with L-dopa in Parkinson's disease].
    Gomirato G; Perfetti CC; Ecari U
    Sist Nerv; 1970; 22(2):67-73. PubMed ID: 5504559
    [No Abstract]   [Full Text] [Related]  

  • 8. A review of some aspects of the pharmacology of levodopa.
    Morris JG
    Clin Exp Neurol; 1978; 15():24-50. PubMed ID: 386308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long-term levodopa syndrome. Report of a clinical case].
    Bossi L; Nobili M
    Arch Sci Med (Torino); 1978; 135(4):637-9. PubMed ID: 756726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Collateral effects of L-dopa treatment in patients with parkinsonism].
    Signorelli CD; D'Andrea F; De Divitiis E
    Sist Nerv; 1970; 22(2):109-14. PubMed ID: 5504548
    [No Abstract]   [Full Text] [Related]  

  • 11. [Acute psychoses and mood disorders in Parkinson disease. Role of antiparkinson therapy].
    Mouren P; Poinso Y; Oppenheim G; Mouren A; Nguyen Quang N
    Ann Med Psychol (Paris); 1983; 141(8):843-57. PubMed ID: 6666915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of dihydroergotamine in the prevention and treatment of orthostatic hypotension syndromes in patients with parkinsonism treated with L-dopa].
    Jubert Gruart J; Balcells Riba M
    Arch Neurobiol (Madr); 1974; 37(4):401-12. PubMed ID: 4433212
    [No Abstract]   [Full Text] [Related]  

  • 13. A second report on Levodopa.
    Med Lett Drugs Ther; 1969 Sep; 11(18):73-5. PubMed ID: 5394281
    [No Abstract]   [Full Text] [Related]  

  • 14. Parkinson's disease and levodopa. A five-year follow-up and review.
    Markham CH; Treciokas LJ; Diamond SG
    West J Med; 1974 Sep; 121(3):188-206. PubMed ID: 4606887
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical and biochemical considerations on depressive states occuring during parkinsonian syndrome treated by L-Dopa].
    Gisselmann A; Boudry C; Marin A; Ballivet J
    Encephale; 1976; 2(2):105-13. PubMed ID: 1278088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [L-dopa therapy for Parkinsonism and its relationship to surgical methods of treatments].
    Vasin NIa; Il'inskiĭ IA; Safronov VA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1974; 74(5):701-6. PubMed ID: 4454895
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of Parkinson's disease with the combination drug L-carbidopa/L-dopa. Report on a 2 years study].
    Hayek J
    Schweiz Med Wochenschr; 1977 Apr; 107(14):474-9. PubMed ID: 847450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Parosmia and anosmia under L-dopa therapy (author's transl)].
    Neundörfer B; Valdivieso T
    Nervenarzt; 1977 May; 48(5):283-4. PubMed ID: 895952
    [No Abstract]   [Full Text] [Related]  

  • 19. Involvement of serotonin in clinical features of Parkinson's disease and complications of L-DOPA therapy.
    Melamed E; Zoldan J; Friedberg G; Ziv I; Weizmann A
    Adv Neurol; 1996; 69():545-50. PubMed ID: 8615179
    [No Abstract]   [Full Text] [Related]  

  • 20. Optimization of levodopa therapy.
    Pfeiffer R
    Neurology; 1992 Jan; 42(1 Suppl 1):39-43; discussion 57-60. PubMed ID: 1549199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.